Paraneoplastic neurological syndrome and its impact on the treatment outcomes of small‐cell lung cancer: A single‐center retrospective analysis
A total of 2.8% of patients had SCLC complicated by PNS, with poor PS observed. However, anticancer therapy led to an improvement in PS and comparable ORR, as well as PFS and OS similar to those observed in patients without PNS. Thus, anticancer therapy should be considered in patients with PNS.
Authors
- Satoru Fujiwara (ORCID: https://orcid.org/0000-0002-9007-3945)
- Kazuma Nagata (ORCID: https://orcid.org/0000-0001-9980-2086)
- Keisuke Tomii (ORCID: https://orcid.org/0000-0002-3524-6217)
- Atsushi Nakagawa
- Ryo Tachikawa
- Yuki Sato (ORCID: https://orcid.org/0000-0002-7829-7524)
- Ryosuke Hirabayashi
- Chigusa Shirakawa
Institutions
- Kobe City Medical Center General Hospital (JP)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2024-10-19
- DOI
- https://doi.org/10.1111/1759-7714.15472
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00